发布求助
文献互助 智能选刊 最新文献

Journal of Medical Toxicology最新文献

筛选
英文 中文
ACMT Comment on Recent Guidance on PFAS Laboratory Testing. ACMT 就 PFAS 实验室测试最新指南发表评论。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-27 Epub Date: 2024-04-18 DOI: 10.1007/s13181-024-01004-1
John W Downs, Nicholas E Nacca, Andrew I Stolbach, Michael G Holland
{"title":"ACMT Comment on Recent Guidance on PFAS Laboratory Testing.","authors":"John W Downs, Nicholas E Nacca, Andrew I Stolbach, Michael G Holland","doi":"10.1007/s13181-024-01004-1","DOIUrl":"10.1007/s13181-024-01004-1","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"334-335"},"PeriodicalIF":2.5,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288227/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140863117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Asymptomatic Patients Need Endoscopy after Caustic Ingestion? 摄入腐蚀性物质后，无症状患者需要进行内窥镜检查吗？
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-27 Epub Date: 2024-04-29 DOI: 10.1007/s13181-024-01009-w
James D Whitledge, Michele M Burns
{"title":"Do Asymptomatic Patients Need Endoscopy after Caustic Ingestion?","authors":"James D Whitledge, Michele M Burns","doi":"10.1007/s13181-024-01009-w","DOIUrl":"10.1007/s13181-024-01009-w","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"254-255"},"PeriodicalIF":2.5,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Ensuring the Efficacy and Safety of Approved Medications ". 就 "确保已批准药物的疗效和安全性 "发表评论。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-27 Epub Date: 2024-05-02 DOI: 10.1007/s13181-024-01005-0
J Oppenheimer, Thomas B Casale, Sarina Tanimoto
{"title":"Comment on \"Ensuring the Efficacy and Safety of Approved Medications \".","authors":"J Oppenheimer, Thomas B Casale, Sarina Tanimoto","doi":"10.1007/s13181-024-01005-0","DOIUrl":"10.1007/s13181-024-01005-0","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"330-331"},"PeriodicalIF":2.5,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JMT Musings: From the Impostor Syndrome to Humility. JMT Musings：从 "冒名顶替综合症 "到 "谦逊"。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-11 Epub Date: 2024-05-28 DOI: 10.1007/s13181-024-01012-1
Leslie R Dye
{"title":"JMT Musings: From the Impostor Syndrome to Humility.","authors":"Leslie R Dye","doi":"10.1007/s13181-024-01012-1","DOIUrl":"10.1007/s13181-024-01012-1","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"251-253"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American College of Medical Toxicology Research Agenda 2024-2030. 美国医学毒理学学院 2024-2030 年研究议程。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-11 Epub Date: 2024-06-04 DOI: 10.1007/s13181-024-01014-z
Neeraj Chhabra, Alison Meyn, Maryann Mazer-Amirshahi, Stephanie P Carreiro, Kevin Maskell, Marielle Brenner, David H Jang, Mark B Mycyk, Paul Wax
{"title":"American College of Medical Toxicology Research Agenda 2024-2030.","authors":"Neeraj Chhabra, Alison Meyn, Maryann Mazer-Amirshahi, Stephanie P Carreiro, Kevin Maskell, Marielle Brenner, David H Jang, Mark B Mycyk, Paul Wax","doi":"10.1007/s13181-024-01014-z","DOIUrl":"10.1007/s13181-024-01014-z","url":null,"abstract":"<p><p>ACMT recognizes the pivotal role of high-quality research in advancing medical science. As such, the establishment of a formal research agenda for ACMT is a leap forward in communicating the priorities of the College, its members, and the patient populations we serve. This thoughtfully crafted agenda will serve as a strategic compass for ACMT, guiding our pursuit of scientific discovery, fostering innovation, and enhancing outcomes for patients and communities affected by poisonings and exposures.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"286-292"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141247793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Safety of Physostigmine for Pediatric Antimuscarinic Poisoning. 更正：物理斯的明治疗小儿抗心绞痛药中毒的安全性。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-11 DOI: 10.1007/s13181-024-01007-y
Sarah Huber, Robert Avera, Shannon Penfound, Adam Overberg, Kristine Nañagas
{"title":"Correction: Safety of Physostigmine for Pediatric Antimuscarinic Poisoning.","authors":"Sarah Huber, Robert Avera, Shannon Penfound, Adam Overberg, Kristine Nañagas","doi":"10.1007/s13181-024-01007-y","DOIUrl":"10.1007/s13181-024-01007-y","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"338-339"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Response to "Comment on Ensuring the Efficacy and Safety of Approved Medications". 回应 "关于确保已批准药物的疗效和安全性的评论"。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-11 Epub Date: 2024-05-03 DOI: 10.1007/s13181-024-01006-z
Maryann Mazer-Amirshahi, Jon B Cole, Andrew I Stolbach, Jeanmarie Perrone, Lewis S Nelson
{"title":"In Response to \"Comment on Ensuring the Efficacy and Safety of Approved Medications\".","authors":"Maryann Mazer-Amirshahi, Jon B Cole, Andrew I Stolbach, Jeanmarie Perrone, Lewis S Nelson","doi":"10.1007/s13181-024-01006-z","DOIUrl":"10.1007/s13181-024-01006-z","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"332-333"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140855299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Patient Registry to Multi-Center Research Consortium: the Toxicology Investigators Consortium (ToxIC) Turns Fifteen. 从患者登记处到多中心研究联盟：毒理学研究者联盟 (ToxIC) 十五岁了。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-11 Epub Date: 2024-06-27 DOI: 10.1007/s13181-024-01020-1
Jeffrey Brent, Paul Wax, Rachel Culbreth, Sharan Campleman, Kim Aldy
{"title":"From Patient Registry to Multi-Center Research Consortium: the Toxicology Investigators Consortium (ToxIC) Turns Fifteen.","authors":"Jeffrey Brent, Paul Wax, Rachel Culbreth, Sharan Campleman, Kim Aldy","doi":"10.1007/s13181-024-01020-1","DOIUrl":"10.1007/s13181-024-01020-1","url":null,"abstract":"<p><p>The Toxicology Investigators Consortium (ToxIC) was launched as a prospective multi-center registry of cases who receive medical toxicology consultations. Now, with over 100,000 cases, the Core Registry continues to address many medical toxicology research questions and has served as the foundation for multiple sub-registries, including the North American Snakebite Registry and the Medications for Opioid Use Disorder sub-registry. ToxIC also has evolved a portfolio of non-registry-based projects utilizing medical toxicology physician site principal investigators who enroll patients through emergency departments, irrespective of whether they received a medical toxicology consultation. These studies include the FDA-ACMT COVID-19 ToxIC Pharmacovigilance Project, which identifies adverse drug reactions related to the treatment of COVID-19, the Fentalog Study a toxico-surveillance study of suspected opioid overdose cases, the Drug Overdose Toxico-Surveillance Reporting Program which enrolls either suspected stimulant or opioid overdose cases, and the just being launched Real-World Examination of Naloxone for Drug Overdose Reversal project. Given ToxIC's experience in multi-center studies and its well-developed infrastructure, it is well-positioned to provide a nimble response on the part of the medical toxicology community to addressing evolving toxicological threats, drug and chemical toxicosurveillance, and other important medical toxicology priorities.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"293-298"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288211/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141457469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Files from the University of California San Diego Medical Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental Dosing Error. 加州大学圣地亚哥分校医学毒理学研究员的病例档案：意外剂量错误导致的新生儿弗来凯尼中毒。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-11 DOI: 10.1007/s13181-024-01018-9
Justin Seltzer, Aaron Schneir
{"title":"Case Files from the University of California San Diego Medical Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental Dosing Error.","authors":"Justin Seltzer, Aaron Schneir","doi":"10.1007/s13181-024-01018-9","DOIUrl":"10.1007/s13181-024-01018-9","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"314-323"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288226/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141590535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. 新生儿和产妇鱼鳞状皮肤病与孕期使用卡瓦有关。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2024-07-11 Epub Date: 2024-06-05 DOI: 10.1007/s13181-024-01016-x
Hannah H Spungen, Kartik Mody, Becky Micetic, Christine Wade, A Min Kang
{"title":"Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy.","authors":"Hannah H Spungen, Kartik Mody, Becky Micetic, Christine Wade, A Min Kang","doi":"10.1007/s13181-024-01016-x","DOIUrl":"10.1007/s13181-024-01016-x","url":null,"abstract":"<p><strong>Introduction: </strong>Kava, a substance derived from the Piper methysticum plant, is enjoying a surge in popularity in the United States due to its purported anxiolytic and analgesic effects. Though ichthyosiform dermopathy is a known adverse effect associated with chronic kava exposure in adults, dermopathy in a newborn due to maternal kava use has not yet been described.</p><p><strong>Case report: </strong>This is a case of a 41-year-old woman who was taking a combination kava/kratom product throughout her pregnancy. She developed an ichthyosiform dermopathy that resolved after she stopped using the product postpartum. Her male infant had a neonatal course complicated by both neonatal opioid withdrawal syndrome, attributed to maternal kratom and buprenorphine use, as well as a diffuse ichthyosiform rash similar to descriptions of kava ichthyosiform dermopathy in adults. His neonatal course was complicated by Group B streptococcus and Serratia marscecens bacteremia (treated with antibiotics) and seizures (treated with lorazepam and phenobarbital). His rash resolved completely by day of life 22. At 9-month outpatient follow-up, he had no dermatologic abnormalities or rash recurrence.</p><p><strong>Discussion: </strong>Maternal kava use during pregnancy may cause fetal dermopathy presenting as an acquired ichthyosis. More public education is needed about the potential consequences of kava use, particularly during pregnancy.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"308-313"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141262113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信